132 related articles for article (PubMed ID: 38817040)
21. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation. A report on 94 cases. Groupe Français de Cytogénétique Hématologique (GFCH).
Hematol Cell Ther; 1996 Apr; 38(2):177-81. PubMed ID: 8931999
[TBL] [Abstract][Full Text] [Related]
23. The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F; Muller M; Chapiro E; Abermil N; Collonge-Rame MA; Daudignon A; Gaillard B; Guzun D; Ittel A; Lefebvre C; Lesesve JF; Mozziconacci MJ; Penther D; Quessada J; Settegrana C; Smagghe L; Terre C; Veronese L; Hirsch P; Troadec MB
Am J Hematol; 2024 Jul; 99(7):1420-1422. PubMed ID: 38613825
[No Abstract] [Full Text] [Related]
24. Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nadal N; Auger N; Bidet A; Nguyen-Khac F
Curr Res Transl Med; 2023; 71(4):103426. PubMed ID: 38016423
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetics in the management of hematological malignancies: Guidelines from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F; Bidet A; Chapiro E; Lefebvre C; Michaux L; Troadec MB
Curr Res Transl Med; 2023; 71(4):103411. PubMed ID: 37984195
[No Abstract] [Full Text] [Related]
26. The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).
Nguyen-Khac F; Bidet A; Daudignon A; Lafage-Pochitaloff M; Ameye G; Bilhou-Nabéra C; Chapiro E; Collonge-Rame MA; Cuccuini W; Douet-Guilbert N; Eclache V; Luquet I; Michaux L; Nadal N; Penther D; Quilichini B; Terre C; Lefebvre C; Troadec MB; Véronèse L
Leukemia; 2022 Jun; 36(6):1451-1466. PubMed ID: 35430613
[TBL] [Abstract][Full Text] [Related]
27. Unusual Ph translocations in the French prospective study on chronic myeloid leukemia. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1985 Apr; 16(4):305-9. PubMed ID: 3856470
[TBL] [Abstract][Full Text] [Related]
28. Acute myelogenous leukemia with an 8;21 translocation. A report on 148 cases from the Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1990 Feb; 44(2):169-79. PubMed ID: 2297675
[TBL] [Abstract][Full Text] [Related]
29. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.
Leroux D; Mugneret F; Callanan M; Radford-Weiss I; Dastugue N; Feuillard J; Le Mée F; Plessis G; Talmant P; Gachard N; Uettwiller F; Pages MP; Mozziconacci MJ; Eclache V; Sibille C; Avet-Loiseau H; Lafage-Pochitaloff M
Blood; 2002 Jun; 99(11):4154-9. PubMed ID: 12010820
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Dastugue N; Lafage-Pochitaloff M; Pagès MP; Radford I; Bastard C; Talmant P; Mozziconacci MJ; Léonard C; Bilhou-Nabéra C; Cabrol C; Capodano AM; Cornillet-Lefebvre P; Lessard M; Mugneret F; Pérot C; Taviaux S; Fenneteaux O; Duchayne E; Berger R;
Blood; 2002 Jul; 100(2):618-26. PubMed ID: 12091356
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Eclache V; Lafage-Pochitaloff M; Lefebvre C; Penther D; Raynaud S; Tigaud I
Ann Biol Clin (Paris); 2016 Oct; 74(5):525-534. PubMed ID: 27546835
[TBL] [Abstract][Full Text] [Related]
32. M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).
Roumier C; Eclache V; Imbert M; Davi F; MacIntyre E; Garand R; Talmant P; Lepelley P; Lai JL; Casasnovas O; Maynadie M; Mugneret F; Bilhou-Naberra C; Valensi F; Radford I; Mozziconacci MJ; Arnoulet C; Duchayne E; Dastugue N; Cornillet P; Daliphard S; Garnache F; Boudjerra N; Jouault H; Fenneteau O; Pedron B; Berger R; Flandrin G; Fenaux P; Preudhomme C; ;
Blood; 2003 Feb; 101(4):1277-83. PubMed ID: 12393381
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique.
Avet-Loiseau H; Daviet A; Brigaudeau C; Callet-Bauchu E; Terré C; Lafage-Pochitaloff M; Désangles F; Ramond S; Talmant P; Bataille R
Blood; 2001 Feb; 97(3):822-5. PubMed ID: 11157506
[TBL] [Abstract][Full Text] [Related]
34. Acute leukemia treated with intensive chemotherapy in patients with a history of previous chemo- and/or radiotherapy: prognostic significance of karyotype and preceding myelodysplastic syndrome. Groupe Francais de Cytogénétique Hématologique (GFCH).
Leukemia; 1994 Jan; 8(1):87-91. PubMed ID: 8289504
[TBL] [Abstract][Full Text] [Related]
35. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.
Coyaud E; Struski S; Prade N; Familiades J; Eichner R; Quelen C; Bousquet M; Mugneret F; Talmant P; Pages MP; Lefebvre C; Penther D; Lippert E; Nadal N; Taviaux S; Poppe B; Luquet I; Baranger L; Eclache V; Radford I; Barin C; Mozziconacci MJ; Lafage-Pochitaloff M; Antoine-Poirel H; Charrin C; Perot C; Terre C; Brousset P; Dastugue N; Broccardo C
Blood; 2010 Apr; 115(15):3089-97. PubMed ID: 20160164
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic study of 75 erythroleukemias.
Lessard M; Struski S; Leymarie V; Flandrin G; Lafage-Pochitaloff M; Mozziconacci MJ; Talmant P; Bastard C; Charrin C; Baranger L; Hélias C; Cornillet-Lefebvre P; Mugneret F; Cabrol C; Pagès MP; Fert-Ferret D; Nguyen-Khac F; Quilichini B; Barin C; Berger R;
Cancer Genet Cytogenet; 2005 Dec; 163(2):113-22. PubMed ID: 16337853
[TBL] [Abstract][Full Text] [Related]
38. Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique.
Cauwelier B; Cavé H; Gervais C; Lessard M; Barin C; Perot C; Van den Akker J; Mugneret F; Charrin C; Pagès MP; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Mozzicconacci MJ; Terré C; Luquet I; Cornillet-Lefebvre P; Laurence B; Plessis G; Lefebvre C; Leroux D; Antoine-Poirel H; Graux C; Mauvieux L; Heimann P; Chalas C; Clappier E; Verhasselt B; Benoit Y; Moerloose BD; Poppe B; Van Roy N; Keersmaecker KD; Cools J; Sigaux F; Soulier J; Hagemeijer A; Paepe AD; Dastugue N; Berger R; Speleman F
Leukemia; 2007 Jan; 21(1):121-8. PubMed ID: 17039236
[TBL] [Abstract][Full Text] [Related]
39. Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Groupe Français de Cytogénétique Hématologique.
Leukemia; 1993 Jan; 7(1):10-9. PubMed ID: 8418369
[TBL] [Abstract][Full Text] [Related]
40. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.
Martiat P; Michaux JL; Rodhain J
Blood; 1991 Jul; 78(1):205-11. PubMed ID: 2070054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
